BofA cuts Rentokil Initial stock price target on slower growth

BofA Securities reduced its price target for Rentokil Initial (NYSE:RTO) to GBP4.15 from GBP4.84, citing slower growth and lower EPS estimates. The stock trades at a P/E of 31.74, 4% above its 52-week low. Rentokil reported a 4.5% revenue increase to $3.589B, missing forecasts. Analysts have mixed views, with some upgrading and others downgrading the stock.

Original reporting
Published Oct 12, 2026, 10:20 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 12, 2026, 10:33 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$RTO
Bearish
high confidence
Mentioned
$RTO
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$RTOBearishMed
01

Why it matters

Analyst target reduction suggests weaker growth expectations, likely prompting short‑term sell pressure.

02

Market read

The downgrade directly affects RTO's valuation and may influence sector peers, but has no broader macro impact.

03

What to watch

Potential U.S. re‑listing and cost‑saving initiatives could mitigate downside if executed successfully.

Relevance 6/10Novelty 6/10Timing: pre‑market today

Background

The article reports BofA's revised price target and earnings estimate cuts for Rentokil Initial following its first‑half results, alongside other analyst opinions.

Company-level read

Ticker impact

$RTOBearishHigh confidence
Context

BofA Securities lowered its price target for Rentokil Initial to GBP4.15, cutting 2027‑28 EPS estimates by 8% after the company's weaker‑than‑expected first‑half results.

Expected impact

likely downside as investors price in lower earnings outlook

Evidence & confidence

Analyst downgrade with a 37% upside reduction and lower EPS guidance directly affects valuation expectations.

Market effects

Pest‑control sector may see broader valuation pressure as analysts reassess growth prospects.

UK‑listed RTO could weigh on European defensive stocks in the near term.

Limited to investors with exposure to Rentokil; no macro‑level effect.

Counterpoint

Some investors may view the target cut as an overreaction and look for a bounce if the company stabilises its US residential lead flow.

Key entities

  • Rentokil Initial Plc

    UK‑based pest‑control services provider listed on NYSE as RTO.

  • BofA Securities

    Bank of America research unit issuing the price‑target downgrade.

Related articles

$RTOMed

What Rentokil Initial (RTO) Said on Its Q3 Earnings Call

Rentokil Initial (RTO) reported Q3 earnings, with international revenue up 5% and organic growth at 3.7%. Pest control saw 5.7% organic growth, while hygiene and wellbeing grew 0.7%, excluding a struggling UK business. The company plans to invest in North American operations and separate residential and commercial pest control. CFO Edgecliffe-Johnson will retire in January. RTO is focused on AI search and PestConnect for customer retention.

$RTOMed

Rentokil Initial expects 2026 profit to meet market forecasts, shares jump

Rentokil Initial reported Q3 2026 organic revenue growth of 3.4%, with total revenue reaching $1.89B. The company expects 2026 profit to meet market forecasts. Shares rose over 8% in London trading. North America and International Pest divisions showed strong performance, with organic growth of 2.4% and 5.7%, respectively. The board approved a $200M share buyback program. CFO Paul Edgecliffe-Johnson will retire in January 2027.

$RTOHighAI 8/10

Why is Rentokil Initial stock rallying today?

Rentokil Initial stock rose 6.8% after reporting Q3 2026 organic revenue growth of 3.4% and total revenue of $1.89 billion. Management confirmed full-year profit expectations and announced a $200m share buyback. Improvements in North America and International Pest segments were noted. CFO Paul Edgecliffe-Johnson will retire in 2027. The stock's gain was driven by company-specific factors.

$RTOMed

Stifel upgrades Rentokil stock rating to buy on valuation

Stifel upgraded Rentokil Initial (RTO) to Buy with a GBP3.90 price target, citing low valuation and potential for improved performance. RTO's stock is down 42% from its 52-week high, with subdued North American growth. Stifel expects cost actions and disposals to support fiscal 2026 adjusted operating profit. Recent revenue growth was 4.5%, but missed forecasts, with concerns about U.S. pest control business.